Cloning and expression of the cDNA for canine interleukin-12

Journal of Interferon and Cytokine Research

Volumn 17, Issue 11, 1997, Pages 713-718

  Okano, Fumiyoshi ^a   Satoh, Masahiro ^a   Yamada, Katsushige ^a  

^a TORAY INDUSTRIES INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; INTERLEUKIN 12;

ANIMAL CELL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; DOG; HUMAN; LYMPHOCYTE PROLIFERATION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; TUMOR;

ANIMALIA; BOVINAE; CANIS FAMILIARIS;

EID: 0030698774     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1997.17.713     Document Type: Article

References (16)

1. GUBLER, U., CHUA, A.O., SCHOENHAULT, D.S., DWYER, C.M., MCCOMAS, W., MOTYKA, R., NABAVI, N., WOLITZKY, A.G., QUINN, P.M., and FAMILLETTI, P.C. (1991). Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. USA 88, 4143-4147.
2. STERN, A.S., PODLASKI, F.J., HULMES, J.D., PAN, Y., QUINN, P.M., WOLITZKY, A.G., FAMILLETTI, P.C., STREMLO, D.L., TRUITT, T., CHIZZONLTE, R., and GATELY, M.K. (1990). Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 87, 6808-6812.
3. KOBAYASHI, M., FITZ, L., RYAN, M., HEWICK, R.M., CLARK, S.C., CHAN, S., LOUDON, R., SHERMAN, F., PERUSSIA, B., and TRINCHIERI, G. (1989). Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170, 827-845.
4. MANETTI, R., PARRONCI, P., GIUDIZI, M.G., PICCINNI, M.-P., MAGGI, E., TRINCHIERI, G., and ROMAGNANI, S. (1993). Natural killer cell stimulatory factor (Interleukin 12) induces T helper type I (TH1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177, 1199-1204.
5. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260, 547-549.
6. MURPHY, E.E., TERRES, G., MACATONIA, S.E., HSIEH, C-S., MATTSON, J., LANIER, L., WYSOCKA, M., TRINCHIERI, G., MURRIER, K., and O'GARRA, A. (1994). B7 and interleukin 12 cooperate for proliferation and interferon γ production by mouse T helper clones that are unresponsive to B7 costimulation. J. Exp. Med. 180, 223-231.
7. BRUNDA, M.J., LUISTRO, L., WARRIER, R.R., WRIGHT, R.B., HUBBARD, B.R., MURPHY, M., WOLF, S.F., and GATELY, M.K. (1993). Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med. 178, 1223-1230.
8. NASTALA, C.L., EDINGTON, H.D., MCKINNEY, T.G., TAHARA, H., NALESNIK, M., BRUNDA, M.J., GATELY, M.K., WOLF, S.F., SCHREIBER, R.D., STEWART, T., STORKUS, W.J., and LOTZE, M.T. (1994). Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J. Immunol. 153, 1697-1709.
9. HEINZEL, F.P., SCHOENHAULT, D.S., RERKO, R.M., ROSSER, L.E., and GATELY, M.K. (1993). Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177, 1505-1509.
10. SYPEK, J.P., CHUNG, C.L., MAYOR, S.E.H., SUBRAMANYAM, J.M., GOLDMAN, S.J., SIEBURTH, D.S., WOLF, S.F., and SCHAUB, R.G. (1993). Production of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177, 1797-1802.
11. GAZZINELLI, R.T., HEINY, S., WYNN, T.A., WOLF, S., and SHER, A. (1993). Interleukin 12 is required for the T-lymphocyte-independent induction of interferon γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA 90, 6115-6119.
12. WYNN, T.A., ELTOUM, I., OSWALD, I.P., CHEEVER, A.W., and SHER, A. (1994). Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosma mansoni, and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J. Exp. Med. 179, 1551-1561.
13. GAZZINELLI, R.T., GIESE, N.A., and MORSE, H.C., III. (1994). In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS). J. Exp. Med. 180, 2199-2208.
14. ULLRICH, A., SHINE, J., CHIRGWIN, J., PICTET, R., TISCHER, E., and RUTTER, W. (1977). Rat insulin gene: construelion of plasmids containing to coding sequences. Science 169, 1313-1319.
15. MARUYAMA, K., WANG, H.-M.A., MIYAJIMA, A., TAKEBE, Y., and ARAI, N. (1991). Transfection of cultured mammalian cells by mammalian expression vectors. In: Methods in Nucleic Acids Research. J.D. Karam, L. Chao, and G.W. Warr (eds.) Boston: CRC Press, p. 283.
16. WHITESIDE, T.L., MIESHER, S., MACDONALD, H.R., and VONFLIEDNER, V. (1986). Separation of tumor-infiltrating lymphocytes from tumor cells in human solid tumors. A comparison between velocity sedimentation and discontinuous density gradients. J. Immunol. Methods 90, 221-223.